Background-Little is known about the contribution of frailty in improving patient-level prediction beyond readily available clinical information. The objective of this study is to compare the predictive ability of 129 combinations of 7 frailty markers (cognition, energy, mobility, mood, nutrition, physical activity, and strength) and quantify their contribution to predictive accuracy beyond age, sex and number of chronic diseases.
INTRODUCTION
Although there remains debate on the conceptual and operational definition of frailty (1, 2) , there has been increasing interest in utilizing frailty as a clinical prognostic tool in order to predict outcomes in individual patients.
Most frailty research has focused on the explanatory ability of frailty, that is, examining frailty as a risk factor for adverse outcomes within a given study population (3) (4) (5) (6) (7) (8) (9) (10) (11) . Some authors interpreted their results to conclude predictive ability, that is, the usefulness of frailty to predict outcomes at the individual-patient and serve as a prognostic tool in a clinical setting (5) (6) (7) (8) (9) (10) 12) . Such inferences, however, are problematic since explanatory and predictive ability are two distinct qualities of a model (13, 14) . A misunderstood point is that even highly significant risk factors identified in explanatory models may not be good predictors (15, 16) . The reason is that achieving predictive ability requires more precision than explanatory ability because 1) risk factors are evaluated by comparing the risk of disease at the ends of the distribution of the risk factor whereas individual-level prediction is evaluated for all individuals (15) and 2) individual-level prediction encompasses an additional source of error over population-level prediction. In fact, Wald et al (16) showed that even an odds ratio as large as 200 contrasting the highest and lowest quintiles of risk would yield a detection rate of no more than 56%.
More recently, there have been a number of papers reporting the predictive ability of frailty models (17) (18) (19) (20) (21) (22) (23) (24) (25) using appropriate measures that quantify predictive ability such as the C statistic, sensitivity and specificity or net reclassification index (26) . However, to our knowledge, no published study has compared the predictive ability of multiple combinations of frailty markers or specifically addressed the contribution of frailty beyond age, sex and the number of chronic diseases, information which is readily available to clinicians. If frailty markers continue to be considered as the basis for a clinical tool (10, 12, 27, 28) , it is imperative that research specifically examine the predictive ability of frailty markers rather than infer from explanatory research.
The objectives of the current study were to identify which combination of frailty markers best predicts the onset of disability and to determine the contribution of the frailty markers in increasing predictive accuracy beyond age, sex and the number of chronic diseases.
METHODS

Data selection
This study is based on data from the Established Populations for Epidemiologic Studies of the Elderly (EPESE), a multi-site prospective cohort study initiated in 1981 of communitydwelling persons 65 years or older in the United States (29) . Two sites -East Boston and Iowa -were selected for our analyses based on the availability of frailty measures. Other variables extracted for this study were sex, age and the number of chronic diseases at baseline as well as disability in activities of daily living (ADL) at baseline and over the follow-up period. Chronic diseases included cancer, circulation problems, diabetes, hypertension, heart problems, joint pain, Parkinson's, respiratory problems, and stroke.
Subjects reported on whether a physician had ever told them they had the condition. ADL disability was defined as being unable or needing help to eat, dress, transfer, bathe or toilet (30) . To study the onset of ADL disability, only initially nondisabled subjects 65 years and older were included. In EPESE-East-Boston, of the 3,809 participants enrolled, 3,210 (84.3%) nondisabled participants were retained for analysis. In EPESE-Iowa, 3,447 (93.9%) of the 3,673 subjects were disability-free and selected for analysis. We analyzed the onset of disability (yes/no) over a 6-year follow-up period based on yearly telephone or in-person assessments. Ethics approval for analysis of these data was obtained by the Research Ethics Committee of the Jewish General Hospital, Montreal, Quebec, Canada.
Measures of frailty markers
Based on a literature review carried out as part of the Canadian Initiative on Frailty and Aging (31) , seven markers of frailty were retained based on clinical and biological plausibility and evidence: cognition, energy, mobility, mood, nutrition, physical activity and strength. Measures for each of the 7 frailty markers were selected within each cohort based on how closely they operationalized the domain, their validity, and their clinical relevance (Supplementary Table 1 ). In order to facilitate the comparison of results between the cohorts, measures were dichotomized into the presence or absence of a frailty marker. Dichotomization of objective measures was based on referenced cutoffs. Cutoffs for selfreported measures were defined based on the literature and favoring sensitivity over specificity in identifying subtle vulnerability. When more than one measure was available for a given marker, the marker was scored positive if any measure was positive. Details on the selection and dichotomization of measures are provided elsewhere (32) .
Frailty models
We compared the predictive ability of all possible combinations of these seven markers and determined which combination had the best predictive ability (i.e. the "best model").
A total of 129 different frailty models were generated and the following comparisons were made: each marker individually (7 models), any combination of 2, 3, 4, 5, 6 or 7 of the 7 markers (120 models) as well as a "count model" including the number of frailty markers present (0 to 7) and the "Cardiovascular Health Study (CHS) model" (5) in which subjects were classified as non-frail (0 markers), pre-frail (1-2 markers) or frail (3-5 markers) based on five markers: nutrition, physical activity, energy, mobility and strength.
Statistical analysis
Model selection-Logistic regression models were employed to examine each model's ability to predict incident disability. All models were adjusted for sex, age, and the number of chronic diseases at baseline. The results of three models were compared: the "best model" (lowest AIC), the "count model" and the "CHS model".
To compare each model's predictive fit, we employed the Akaike Information Criterion (AIC) value associated with each regression model. The AIC provides a means of comparing models balancing accuracy of prediction with model parsimony. The model with the lowest AIC value represents the model with the best predictive fit and is the preferred model. A graphical display comparing the AIC values for all 129 models was produced for each cohort.
Measures of predictive accuracy-Two measures were used to quantify the predictive accuracy of the models: the C statistic and the Hosmer-Lemeshow test. The C statistic (33) was used to assess the model's ability to discriminate between high and low risk subjects. For a binary outcome, the C statistic is identical to the area under the receiver operating characteristic (ROC) curve. Values of the C statistic can range from 0 to 1, with values over 0.7 indicating good predictive accuracy of the model. In order to assess predictive accuracy for subjects outside the sample used to create the model, a cross-validated C statistic was used based on a 10-fold jackknife technique. The Hosmer-Lemeshow test (34) was used to test the calibration fit of each model, that is, how closely the model's predicted probabilities agree with the observed proportion of subjects with incident disability. P > .05 suggests adequate model calibration.
Contribution of frailty markers in improving predictive accuracy-To determine the contribution of the frailty markers in improving predictive accuracy, the C statistic from each adjusted model was compared to the C statistic from a model including only age, sex and the number of chronic diseases present at baseline. The difference between the two C statistics corresponds to the contribution of the frailty markers in improving the prediction of incident disability, beyond age, sex and the number of chronic diseases. The Delong et al test (35) was used to assess whether the difference was statistically significant. In addition, differences in C statistic values between the "best model", "count model" and "CHS model" were also tested. P < .05 was considered statistically significant.
Analyses were also conducted stratifying by age group to explore the potential changes in the contribution of frailty markers at different age groups.
Missing Data-Missing data were imputed using multiple imputation (36) . The regression model for each of the 129 frailty models was run for 1,000 imputed datasets and the regression results combined using formulas derived by Rubin (36) . The reported odds ratios and 95% confidence intervals correspond to the averaged regression results. Measures of fit, including AIC values, C statistics and Hosmer-Lemeshow statistics were also averaged across the imputed datasets.
RESULTS
The mean age of study subjects was 72.9 (SD=6.2) in EPESE-Boston and 74.4 (SD=6.5) in EPESE-Iowa (Table 1 ). The proportion of women was 61% in both cohorts. The mean number of chronic diseases ranged from 1.6 (SD=1.3) in EPESE-Boston to 2.0 (SD=1.2) in EPESE-Iowa. The mean number of frailty markers was 1.7 (SD=1.4) in EPESE-Boston and 1.4 (SD=1.3) in EPESE-Iowa. The proportion of subjects classified as frail according to the CHS model was 9.7% in EPESE-Boston and 6.8% in EPESE-Iowa. Six-year incidence of disability in activities of daily living (ADL) was 23% in EPESE-Boston and 20% in EPESEIowa.
When comparing the 129 combinations of frailty markers from best to worst model fit, we found that the inclusion of multiple markers generally improved performance with single markers being among the worst (Supplementary Figure 1) . The "CHS model" and "count model" were among the better models but neither was optimal. The "best model" in each cohort was found to be a model combining between 5 and 7 of the seven frailty markers (Table 2) . Cognition, mobility, nutrition, physical activity and strength were included in the "best model" in both cohorts. The "best model" in EPESE-Iowa included all 7 markers. Table 2 presents the logistic regression results as well the measures of predictive accuracy for the "best model", "count model" and "CHS model". Each of the markers was found to be a statistically significant risk factor for incident disability. In terms of predictive accuracy, the C statistic for the three models was 0.76 in EPESE-Boston and from 0.77 to 0.78 in EPESE-Iowa. All models showed good calibration fit. Figure 1 shows the contribution of the frailty markers to the model C statistic beyond age, sex and the number of chronic diseases. The C statistic for age, sex and chronic disease was 0.73 in EPESE-Boston and 0.74 in EPESE-Iowa. In the "best model", the addition of the frailty markers increased the C statistic by 0.034 to 0.76 in EPESE-Boston and by 0.033 to 0.77 in EPESE-Iowa (P < .001). Increases in the C statistic for the "count model" and the "CHS model" were similar.
When comparing across models, no statistically significant difference in the C statistic was found between the "best model" and the "count model" (P = .37 in EPESE-Boston and P = .
30 in EPESE-Iowa). The difference between the "best model" and the "CHS model" did not reach the conventional level of significance in EPESE-Boston (P = .074) or EPESE-Iowa (P = .059). Figure 2 shows the separate contribution of age and sex, chronic disease and frailty to model accuracy by age group. C statistic values across age groups for age and sex alone were similar in both cohorts with values between 0.51 and 0.67. The contribution of chronic disease decreased from 0.11 in the 65 to 69 age group to 0.007 in the 80 and over in EPESEBoston and from 0.070 to 0.022 in EPESE-Iowa. Conversely, the frailty contribution increased in older age groups from 0.043 to 0.088 in EPESE-Boston and from 0.057 to 0.078 in EPESE-Iowa.
COMMENT
This study is, to our knowledge, the first to compare the predictive fit of all possible combinations of seven of the most accepted frailty markers (1) , including the CHS model (5) . This is also the first study to examine if, and by how much, frailty markers add to patient-level prediction of the onset of disability beyond age, sex and the number of chronic diseases. Six other studies have investigated the contribution of frailty to model prediction. However, these studies considered either a specific frailty model or marker (19, 22, 25) or a selected population (19) (20) (21) (23) (24) (25) . In addition, the studies did not focus on what frailty adds to the prediction based on information readily accessible to the clinician such as age, sex and the number of chronic diseases.
In our study, the "best model" with the best predictive fit was a model with 5 of the 7 markers in one cohort and all 7 markers in the other cohort. The five markers in common to both models were cognition, mobility, nutrition, physical activity and strength. For the "best model", the addition of frailty markers increased predictive accuracy by 3% in both cohorts. When stratifying by age group in both cohorts, we found that the contribution of frailty markers increased the C statistic by up to 9% in subjects 80 years and over while the contribution of chronic disease decreased in older age groups.
One could argue that it is not worth a busy clinician's time to conduct assessments to measure frailty markers in light of apparently modest improvements in patient-level prediction. Nevertheless, while age, sex and the number of chronic diseases are not modifiable, there is potential to improve the health and functional status with an impact on the frailty status of older persons by interventions such as nutrition and exercise programs (37, 38) . This may be especially worthwhile in older age groups, where we found evidence that predictive accuracy of frailty markers is highest.
The strengths of this study include the analysis of two separate cohorts of older persons, the comparison of a large number of potential frailty models and the use of sophisticated imputation methods for missing data. In addition, this study employed rigorous methods for the reporting of C statistics using cross-validation in order to reflect accurate model discrimination in out-of-sample persons and statistical testing for differences in C statistic values. Such rigorous techniques were found in only two other frailty studies (17, 21) .
This study also had limitations. Measures for the seven frailty markers were limited to what was available within the EPESE study. Our decision to dichotomize the measures, while necessary to facilitate the interpretation of results, may have resulted in a loss of information. Because proportions of missing data were as high as 29% for some variables, results may have differed with complete data rather than imputed values.
In conclusion, the results of this study highlight a common misconception in the frailty literature between the explanatory and predictive ability of frailty markers. Our results suggest that, although frailty markers appear to be significant risk factors at the population level, they may have modest value in predicting at the individual level, beyond age, sex and the number of chronic diseases. However, even a relatively small increase in predictive accuracy may be worthwhile because while age, sex and the number of chronic diseases are not modifiable, frailty may be. Results also provide evidence that frailty, as a prognostic tool, may play a more important role among the 80 and over group. While this study focused on the ability of frailty markers to predict incident disability in two population-based cohorts, one cannot infer that the same frailty markers will also be predictive for other adverse outcomes of interest in this same population or in other populations and settings (39, 40) . Moreover, predictive accuracy may be improved when combining frailty markers with existing predictive clinical scores (20, 25) . Despite the enthusiasm and impatience of clinicians and researchers to utilise frailty as a prognostic instrument (10, 12, 27, 28) , further studies examining the contribution of frailty in improving prediction in different outcomes, settings and populations are needed before adopting frailty as a clinical tool. Ultimately frailty will only be relevant if health promotion and prevention intervention studies can demonstrate that either frailty is reversible or that the adverse outcomes can be modified or, at least, delayed.
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